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ABSTRACT
Cloxyquin has been reported as a specific activator of TRESK
[TWIK-related spinal cord K1 channel (also known as K2P18.1)]
background potassium channel. In this study, we have synthe-
tized chemically modified analogs of cloxyquin and tested their
effects on TRESK and other K2P channels. The currents of murine
K2P channels, expressed heterologously in Xenopus oocytes,
were measured by two-electrode voltage clamp, whereas the
native background K1 conductance of mouse dorsal root gan-
glion (DRG) neuronswas examined by the whole-cell patch-clamp
method. Some of the analogs retained the activator character of
the parent compound, but, more interestingly, other derivatives
inhibited mouse TRESK current. The inhibitor analogs (A2764 and
A2793) exerted state-dependent effects. The degree of inhibition
by 100 mM A2764 (77.8% 6 3.5%, n 5 6) was larger in the
activated state of TRESK (i.e., after calcineurin-dependent stim-
ulation) than in the resting state of the channel (42.8% 6 11.5%
inhibition, n 5 7). The selectivity of the inhibitor compounds
was tested on several K2P channels. A2793 inhibited TWIK-
related acid-sensitive K1 channel (TASK)-1 (100 mM, 53.4% 6
13, 5%, n 5 5), while A2764 was more selective for TRESK, it
only moderately influenced TREK-1 and TWIK-related alkaline
pH-activated K1 channel. The effect of A2764 was also examined
on the background K1 currents of DRG neurons. A subpopulation
of DRG neurons, prepared from wild-type animals, expressed
background K1 currents sensitive to A2764, whereas the inhibitor
did not affect the currents in the DRG neurons of TRESK-deficient
mice. Accordingly, A2764 may prove to be useful for the identifi-
cation of TRESK current in native cells, and for the investigation
of the role of the channel in nociception and migraine.
SIGNIFICANCE STATEMENT
TRESK background potassium channel is a potential pharma-
cological target in migraine and neuropathic pain. In this study,
we have identified a selective inhibitor of TRESK, A2764. This
compound can inhibit TRESK in native cells, leading to cell
depolarization and increased excitability. This new inhibitor may
be of use to probe the role of TRESK channel in migraine and
nociception.
Introduction
Background (leak) potassium currents are responsible
for the generation of the resting membrane potential and
also play an important role in the adjustment of cellular
excitability. The molecular correlates of the background
potassium currents are the two-pore domain potassium
channels (K2P). To date, 15 K2P subunits have been identi-
fied in mammalian cells. These channels are regulated by
a large variety of physicochemical factors, intracellular
signaling pathways, and drugs (for review, see Enyedi and
Czirják (2010).
This work was supported by the Hungarian Research Fund [Grant NKFIH
K-127988] and the Higher Education Institutional Excellence Program of the
Ministry of Human Capacities in Hungary, within the framework of the Molecular
Biology thematic program of the Semmelweis University. M.L. was supported by
the New National Excellence Program of the Ministry of Human Capacities
[ÚNKP-18-3-III-SE-43] and [EFOP-3.6.3-VEKOP-16-2017-00009, program name:
“Az orvos-, egészségtudományi- és gyógyszerészképzés tudományos m}uhelyeinek
fejlesztése”]. No potential conflicts of interest relevant to this article are reported.
1Current affiliation: Hungarian Accreditation Committee, Budapest, Hungary.
2Current affiliation: Faculty of Health and Public Services, Semmelweis
University, Budapest, Hungary.
https://doi.org/10.1124/mol.118.115626.
s This article has supplemental material available at molpharm.aspetjournals.org.
ABBREVIATIONS: cRNA, complementary RNA; DRG, dorsal root ganglion; KO, knockout; K2P, two-pore domain potassium channel; mTRESK,
mouse tandem of pore domains in a weak inward rectifying K1 channel–related spinal cord K1 channel; RR, ruthenium red; TALEN, transcription
activator–like effector nuclease; TALK, TWIK-related alkaline pH-activated K1 channel; TASK, TWIK-related acid-sensitive K1 channel; THIK,
tandem pore domain halothane-inhibited K1 channel; TREK, TWIK-related K1 channel; TRAAK, TWIK-related arachidonic acid-stimulated K+
channel; TRESK, TWIK-related spinal cord K1 channel; TWIK, tandem of pore domains in a weak inward rectifying K1 channel.
652
http://molpharm.aspetjournals.org/content/suppl/2019/04/11/mol.118.115626.DC1
Supplemental material to this article can be found at: 
 at A
SPET Journals on D
ecem
ber 10, 2019
m
olpharm
.aspetjournals.org
D
ow
nloaded from
 
TRESK [TWIK-related spinal cord K1 channel (also known
as K2P18.1)] was first cloned from human spinal cord (Sano
et al., 2003). TRESK is activated by the cytoplasmic Ca21
signal, via the calcium/calmodulin-dependent phosphatase
calcineurin (Czirják et al., 2004). TRESK is abundantly
expressed in the primary sensory neurons of the dorsal root
(DRG) (Yoo et al., 2009) and trigeminal ganglion (Bautista
et al., 2008; Yamamoto et al., 2009). Single-channel studies
indicated that TRESK provides a major component of the
background potassium current in rat DRG neurons (Kang
and Kim, 2006). It is a plausible hypothesis that TRESK
modulates the activity of sensory neurons and the absence
of TRESKcurrent results in an increased excitability, leading to
disorders in nociception. A decrease of TRESK expression has
been reported in a model of neuropathic pain (Tulleuda et al.,
2011). In further support of this hypothesis, a mutation of
TRESK leading to a nonfunctional channel fragment with
dominant-negative effect has been recognized in a cohort of
patients suffering from migraine (Lafrenière et al., 2010).
To understand the role of TRESK in physiological and
pathophysiological nociception, appropriate pharmacological
tools are necessary for selective modulation of the channel.
However, pharmacological targeting of TRESK and other
K2P channels is a difficult task (for a recent review on the
pharmacology of TRESK, see Enyedi and Czirják, 2015).
The antiamoebic drug cloxyquin was identified as an
activator of TRESK (Wright et al., 2013). We have recently
reported that cloxyquin is a selective activator of TRESK
in the K2P family. The stimulatory effect of cloxyquin was
independent of the Ca21/calcineurin pathway, suggesting that
cloxyquin is a direct activator of the channel. We have also
shown that cloxyquin activates TRESK in isolated mouse
DRG neurons (Lengyel et al., 2017). In the present study, we
have produced 28 chemically modified analogs of cloxy-
quin and examined their effects on TRESK channels.
Some of these derivatives activated TRESK with similar
efficiency and potency as the parent compound. On the
other hand, we obtained several compounds suitable for
the selective inhibition of TRESK current in an activation
state–dependent manner.
Materials and Methods
Plasmids, Complementary RNA Synthesis. The cloning of
mouse TWIK-related acid-sensitive K1 channel (TASK)-1/2/3, TWIK-
related K1 channel (TREK)-2, TWIK-related alkaline pH-activated
K1 channel (TALK)-1, tandem pore domain halothane-inhibited K1
channel (THIK)-1, and TRESK has been described previously
(Czirják et al., 2004; Czirják and Enyedi, 2006). The plasmids coding
mouse TREK-1 and TRAAK channels were provided by Professor M.
Lazdunski and Dr. F. Lesage (Institut de Pharmacologie Moleculaire
et Cellulaire -CNRS -UPR 411, 660 route des Lucioles, Sophia
Antipolis, 06560 Valbonne, France). The plasmids were linearized
and used for in vitro complementary RNA (cRNA) synthesis using the
mMESSAGE mMACHINE T7 in vitro transcription kit (Ambion,
Austin, TX). The structural integrity of the RNA was checked on
denaturing agarose gels.
Animal Husbandry, Preparation, and Microinjection of
Xenopus Oocytes. Generation of a TRESK Knockout Mouse
Line: Isolation of DRG Neurons. Xenopus laevis oocytes were
prepared as previously described (Czirják and Enyedi, 2002). For the
expression of the different channels, the oocytes were injected with
57 pg to 4 ng of cRNA (depending on the channel type) 1 day after
defolliculation. Injection was performed with a Nanoliter Injector
(World Precision Instruments, Sarasota, FL). X. laevis frogs were
housed in 50-l tanks with continuous filtering and water circulation.
Room temperature was 19°C. Frogs were anesthetized with 0.1%
tricaine solution and killed by decerebration and pithing.
FVB/Ant (FVB.129P2-Pde6b1Tyrc-ch/Ant) mice were obtained
from the Institute of Experimental Medicine of the Hungarian
Academy of Sciences (Budapest, Hungary). TRESK knockout (KO)
animals were generated by the transcription activator–like effector
nuclease (TALEN) technique using plasmids ordered from Addgene
(TALE Toolbox Kit number 1000000019, deposited by Feng Zhang)
(Broad Institute of MIT and Harvard). Mouse TRESK (mTRESK)-
specific TALEN recognition sites were designed for the genomic
sequence of the first exon (corresponding to the N-terminal intracel-
lular domain of the channel) using the 59-TN19 N14220 N19A-39
formula, with the following sequences: left TALEN recognition site,
59tgaggagccacctgaggcca; right TALEN recognition site, 59ccctgg-
ggaaggccagggga; and an 18 base pair (59ggagatgctgtcctgagg) FokI
nuclease dimerization and cutting sequence in between. mTRESK
recognizing TALEN plasmids were assembled according to the pro-
tocol of Sanjana et al. (2012). TALENmRNAswere produced using the
Ambion mMESSAGE mMACHINE T7 in vitro transcription kit
(Ambion). TALEN mRNAs were microinjected at a concentration of
20–20 ng/ml into the pronuclei of fertilized eggs of FVB/Antmice. Pups
were analyzed with Surveyor assay plus sequencing. In 12 mice,
among the 61 born pups the TRESK (KCNK18) gene was changed,
and a founder bearing a 33 base pair deletion and also a mutation
introducing a stop codon was chosen to establish a colony.
Adult female wild-type and TRESK KO mice (2–3 months of age)
were used for the patch-clamp experiments in this study. The animals
were maintained on a 12-hour light/dark cycle with free access to food
and water in a specific pathogen-free animal facility. Mice were killed
humanely by CO2 exposure (CO2 was applied until death of the
animals). DRGs were dissected from the thoracic and lumbar levels of
the spinal cord and collected in sterile PBS (137 mM NaCl, 2.7 mM
KCl, and 10 mM NaH2PO4, pH adjusted to 7.4 with NaOH) at 4°C.
Ganglia were incubated in PBS containing 2 mg/ml collagenase
enzyme (type I; Worthington Biochemical Corporation, Lakewood,
NJ) for 30 minutes with gentle shaking at 37°C. For further details
regarding the isolation and culturing of the cells, see Braun et al.
(2015). All experimental procedures using animals were conducted in
accordance with theGuide for the Care andUse of Laboratory Animals
as adopted by the National Institutes of Health, local state laws,
and institutional regulations. All animal experiments were approved
by the Animal Care and Ethics Committee of Semmelweis Univer-
sity (approval ID: XIV-I-001/2154-4/2012).
Two-Electrode Voltage-Clamp and Patch-Clamp Measure-
ments. Two-electrode voltage-clamp experiments were performed
1–3 days after the microinjection of cRNA into Xenopus oocytes, as
previously described (Czirják et al., 2004). For each channel type, the
oocytes contributing to the n number (the exact n number is indicated
in the text or on the figures) were derived fromat least two, but usually
three, separate frogs. The holding potential was 0 mV. Background
potassium currents were measured at the end of 300-millisecond-long
voltage steps to2100 mV applied every 4 seconds. The low-potassium
recording solution contained the following (in mM): NaCl 95.4, KCl 2,
CaCl2 1.8, and HEPES 5, at pH 7.5, adjusted by NaOH. The high-
potassium solution contained 80 mM K1 (78 mM NaCl in the low-
potassium solution was replaced with KCl). For the measurement
of TREK-1, TREK-2, and TRAAK currents, the high-potassium solu-
tion contained 40 mM K1. Solutions were applied to the oocytes
using a gravity-driven perfusion system. Experimentswere performed
at room temperature (21°C). Data were analyzed by pCLAMP
10 software (Molecular Devices, Sunnyvale, CA).
Whole-cell patch-clamp experiments in the voltage-clamp configu-
ration were performed as described previously (Lengyel et al., 2016).
The resting membrane potential was recorded in the current-clamp
mode with no current injection (I 5 0 mode). The rheobase was
determined by injecting depolarizing current (in 100 pA increments,
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up to 1500 pA) for 1 second every 4 seconds. Isolated DRG neurons
were used for experiments 1 to 2 days after isolation. For the current-
clamp study of DRG neurons, only cells with a membrane potential
between 245 and 270 mV were accepted, as described in previous
studies (Petruska et al., 2000). Because the focus of this study was to
examine the effects of our new cloxyquin analogs on the electrophys-
iological parameters of isolated DRG neurons, no other selection
criteria were used. The cutoff frequency of the eight-pole Bessel filter
was adjusted to 200 Hz, and data were acquired at 1 kHz. The pipette
solution contained (in mM): 140 KCl, 3MgCl2, 0.05 EGTA, 1 Na2-ATP,
0.1 Na2-GTP, and 10 HEPES. The low-potassium solution contained
(in mM): 140 NaCl, 3.6 KCl, 0.5 MgCl2, 2 CaCl2, 11 glucose, and
10 HEPES. The high-potassium solution contained 30 mM KCl
(26.4 mM NaCl of the low-potassium solution was replaced with
KCl). The pH of the bath solutions was adjusted to 7.4 with NaOH.
Experiments were performed at room temperature (21°C). Data were
analyzed using pCLAMP 10.7 software (Molecular Devices).
Data and Statistical Analysis. Results are expressed as the
mean 6 S.D. Normalized concentration-response curves were fitted
with the following modified Hill equation: a  cn/[ cn 1 K1/2n ] 1 1,
where c is the concentration, K1/2 is the concentration at which half-
maximal stimulation occurs, n is the Hill coefficient, and a is the effect
of the treatment. The normality of the data was estimated using the
Shapiro-Wilk test. If the Shapiro-Wilk test showed a significant
difference between the examined groups, statistical significance was
determined using the Mann-Whitney U test. Otherwise, statistical
significance was determined with the Student’s t test or Fisher’s
ANOVA followed by Tukey’s post hoc test for multiple groups. Results
were considered to be statistically significant at P , 0.05. The
difference in sample sizes among different groups is a consequence
of the differing number of cells suitable for experimentation; sample
sizes were not modified after obtaining initial results. The determined
P values are descriptive and not the result of testing prespecified
hypotheses. Curve fitting was performed using SigmaPlot10 (Build
10.0.0.54; SyStat Software, San Jose, CA). Statistical calculations
were performed using Statistica (version 13.2; Dell, Round Rock, TX).
Materials. Chemicals of analytical grade were purchased from
Sigma-Aldrich (St. Louis, MO), Fluka (Milwaukee, WI), and Merck
(Whitehouse Station, NJ). Enzymes and kits for molecular biology were
purchased fromAmbion, ThermoFisher Scientific (Waltham,MA),New
EnglandBiolabs (Beverly,MA), or Stratagene (La Jolla, CA). Cloxyquin
and ruthenium red (RR)were purchased fromSigma-Aldrich. Ionomycin
(calcium salt) was purchased from Enzo Life Sciences, Inc. (Farmington,
NY), dissolved in DMSO as a 5 mM stock solution, and stored at220°C.
Synthesis and chemical analysis of the new compounds described in this
study are detailed in the Supplemental Material.
Results
A2764 Is a State-Dependent Inhibitor of Mouse
TRESK Channel. Wehave synthesized 28 compounds struc-
turally similar to cloxyquin and tested their effects on
mTRESK channels expressed in X. laevis oocytes using the
two-electrode voltage-clamp technique. The background K1
current was estimated at 2100 mV in an extracellular solu-
tion containing high K1 (80 mM) after the subtraction of the
small nonspecific leak current measured in 2 mM K1. Seven
derivatives had a stimulatory effect on mTRESK activity in a
manner similar to that of cloxyquin, 10 compounds did not
influence the K1 current, while 11 analogs inhibited the
channel. Based on our pilot screening of the compounds, the
most promising inhibitors (A2764 andA2793) and an activator
(A2797) ofmTRESKwere chosen for in-depth analysis. For the
chemical structure of the novel cloxyquin analogs, see Fig. 1
(for the chemical structures of the new compounds and details
of synthesis and chemical analysis for A2764 and A2793, see
the chemical structures of compounds and the Supplemental
Material).
The backgroundK1 current was inhibited by 42.8%6 11.5%
when A2764 (100 mM) was applied to the oocytes expressing
mTRESK (n5 7 oocytes) (Fig. 2A). In addition to the inhibition
of the basal current, we also examined the effect of A2764 on
the current of activated mTRESK. Ionomycin was used to
evoke the elevation of the cytoplasmic [Ca21], which has been
previously shown to activate the channel by dephosphoryla-
tion via the stimulation of the serine phosphatase calcineurin
(Czirják et al., 2004). When mTRESK current was increased
7.1 6 1.8-fold by the pretreatment with ionomycin (0.5 mM),
the subsequent application of A2764 (100 mM) strongly
inhibited the current (77.8%6 3.5% inhibition, n5 6 oocytes)
(Fig. 2B). The effect of A2764 on mTRESK activated by
dephosphorylation was more pronounced than the inhibition
of the basal current (P, 0.05,Mann-WhitneyU test) (Fig. 2C).
The concentration dependence of the channel inhibition was
also shifted; while the IC50 value evoked by A2764 was 11.8
mM for the activated channel, the inhibitory potency of the
drug was an order of magnitude lower for mTRESK in the
resting state (Fig. 2D).
A2764 Is the Most Selective Modulator Among the
Cloxyquin Analogs, Tested Among a Wide Range of K2P
Channels. To estimate the selectivity of the novel cloxyquin
analogs within the K2P subfamily, we tested them on several
mouse K2P channels (at least one member from each subfamily
being functional under physiologic ionic conditions): TASK-1
(K2P3.1), TASK-2 (K2P5.1), TASK-3 (K2P9.1), TALK-1 (K2P16.1),
TREK-1 (K2P2.1), TREK-2 (K2P10.1), TRAAK (K2P4.1), and
THIK-1 (K2P13.1). The channels were expressed in Xenopus
oocytes, and the effect of the compounds was measured by two-
electrode voltage clamp (n 5 5–7 oocytes per channel type).
Among the three examined cloxyquin analogs, A2764 proved to
Fig. 1. Chemical structures of novel cloxyquin deriva-
tives. Chemical structures of the new cloxyquin analogs
reported in this study (A2764, A2793, and A2797). The
structure of the parent compound is shown for
comparison.
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be the most selective agent; it inhibited the current of TRESK
under resting conditions and in the activated state by 42.8% 6
11.5% (n 5 7) and 77.8% 6 3.5% (n 5 6), respectively (Fig. 3).
TREK-1 and TALK-1 currentswere reduced only by about 20%,
while the other channels were even less affected. The difference
in the degree of inhibition between TRESK (both in the resting
and in the activated state) and all the examined K2P channels
was statistically significant.
The efficiency of the other tested inhibitory analog (A2793)
was higher than that of A2764. At 100 mM concentration,
A2793 inhibited the unstimulated channel by 43.0% 6 8.9%
(n 5 5), whereas after ionomycin activation the reduction
of the TRESK current was 85.5% 6 2.9% (n 5 5) and was
practically reduced to the nonactivated level (Fig. 4, A and B).
The concentration-response relationship was also determined
for both the activated and the basal mTRESK currents (Fig.
4D). The activated channel was inhibited with an IC50 of 6.8
mM,whereas the inhibitory potency of the compoundwasmore
than an order of magnitude smaller in the case of TRESK at
basal activity. The specificity of A2793 showed a strikingly
different pattern from A2764; it inhibited TASK-1 by 53.4%6
13.5% (n5 5), while all the other channels were influenced by
less than 20% (Fig. 4C). These properties may have advantage
under experimental conditions when the presence of TASK-1
can be excluded. This was not the case in our studies on native
DRG cells, accordingly, we used A2764 in our subsequent
experiments.
The chemical structure of the activator analog (A2797)
differed in the aromatic ring from cloxyquin. Its potency was
not favorable compared with cloxyquin, and it activated
TRESK to a similar degree (437.6% 6 139.8% of control, n 5
9 oocytes) as the parent compound. Unlike cloxyquin, it
activated other K2P channels (TREK-2, TASK-2, and TRAAK)
in addition to TRESK (details of these data are available in
Supplemental Fig. 1).
Fig. 2. A2764 is a state-dependent inhibitor of
mTRESK. (A) Normalized currents of oocytes expressing
mTRESK, measured by the two-electrode voltage-clamp
technique. Currents were measured at the end of 300-
millisecond voltage steps to 2100 mV applied every
4 seconds from a holding potential of 0 mV. The
extracellular K+ concentration was increased from 2 to
80mM, as indicated by the bars above the graph. Oocytes
were challenged with A2764 (100 mM; see the horizontal
bar). Currents were normalized to the value measured in
80 mMK+ before the application of the drug. The current
measured in 80 mM K+ before the application of A2764
was 2.96 1.5mA.Data are plotted as themean6S.D. (B)
The effect of A2764 on the activated mTRESK channels
was determined under the same experimental conditions
as in (A). The current measured in 80 mM K+ before
the application of ionomycin was 1.5 6 0.8 mA. The
TRESK current was activated by the application of 0.5
mM ionomycin (by 7.1 6 1.8 fold), which was followed
by the addition of A2764 (100 mM) to the bath solution
(the timing of the changes of K+ concentration and drug
application are marked by horizontal bars above the
graph). Currents were normalized to the value measured
after ionomycin stimulation, before the application of
A2764. (C) The data from (A and B) have been summa-
rized as a column graph. Mean inhibitions of the resting
and activated TRESK currents are plotted, and the
number of oocytes in each group is given in parenthe-
ses. The difference in the degree of inhibition was
statistically significant (*: P , 0.05, Mann-Whitney
U test). (D) Concentration-response relationship of
A2764 and mTRESK current. The inhibitory effects of
different concentrations of A2764 (in a range from 1 to
100 mM) on basal (white circles) and activated (black
diamonds) TRESK current are plotted. Each data point
represents the average of 5–11 oocytes (the exact
number is indicated in parentheses). The data points
were fitted with amodified Hill equation (seeMaterials
and Methods).
Fig. 3. A2764 is a selective inhibitor of mTRESK. Mouse K2P channels
were expressed in Xenopus oocytes. The effect of A2764 (100 mM) on the
inward current in 80mMextracellular K+ (or 40mM in the case of TREK-1,
TREK-2, and TRAAK) was determined in 5–7 oocytes per channel type, as
in Fig. 2A. As a comparison, the data points corresponding to the inhibition
of basal or activated TRESK current from Fig. 2 are also plotted. Themean
inhibition for each channel type is plotted as a column graph. The error
bars represent the S.D. iono, ionomycin.
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A2764 Inhibits the Background K1 Currents in DRG
Neurons. To examine the TRESK current in native cells by
the application of A2764, we isolated DRG neurons and
performed whole-cell patch-clamp recordings. Since the func-
tional state of TRESK in cell culture may vary depending on
inhibitory kinases and the calcium homeostasis of the neuron,
we uniformly induced calcineurin-dependent TRESK dephos-
phorylation by adding 0.5 mM ionomycin to our recording
solutions before the application of A2764. In addition to the
inhibitory effect of A2764 (100 mM), the sensitivity of the
currents toRR (30mM)was also examined. It iswell established
that TREK-2, TRAAK, and TASK-3 K2P channels are inhibited
by RR, and TREK-2 and TRAAK were previously reported to
be expressed in large subpopulations of DRG neurons.
We applied the two inhibitors (A2764 and RR) into the bath
solution successively. A recording from a representative,
A2764-sensitive DRG neuron is shown in Fig. 5A. The
sensitivity of the background current of the examined indi-
vidual cells to A2764 and RR is presented on a scatter plot; 6 of
the examined 10 cells showed substantial A2764 sensitivity
(above 40%), whereas in the other four cells the degree of
inhibition was below 20% (Fig. 5B). At the same time, we
observed a significant negative correlation (r 5 20.9499, P ,
1024, Pearson’s correlation coefficient) between the ampli-
tudes of A2764-sensitive and RR-sensitive current compo-
nents (Fig. 5B). The current remaining after the elimination
of the A2764-sensitive component was substantially reduced
by RR (the residual current was 16%6 9.2%), suggesting that
the A2764-sensitive (TRESK) and RR-inhibited (most proba-
bly TREK-2 and TRAAK) currents were mainly responsible
for the background K1 conductance in the majority of DRG
neurons of the examined unselected population.
To validate the assumption that the A2764-sensitive cur-
rent component of these native cells was indeed TRESK
current, we also performed whole-cell patch-clamp experi-
ments in the DRG neurons from TRESK KO mice under
identical conditions. As shown on a representative recording
in Fig. 5C, the application of A2764 (100 mM) had no effect, but
RR substantially inhibited the background K1 current in this
neuron. As apparent on the scatter plot in Fig. 5D, A2764
(100 mM) did not influence the background K1 current of the
DRG neurons derived from the TRESK KO animals (the
average effect on the K1 current was marginal, 6.5% 6
15.8% inhibition, n 5 8). This was significantly different from
the substantial inhibition of the current in the wild-type cells
(43.0%6 29.7%, n5 10; P, 0.05, Mann-WhitneyU test). This
result indicates that the A2764-sensitive component corre-
sponds to TRESK current, and A2764 is suitable for the
investigation of the channel in native cells.
A2764 Increases the Excitability of DRG Neurons.
The effect of A2764 on the resting membrane potential and
excitability of wild-type and TRESK KO DRG neurons was
determined by using the current-clamp technique. In the
case of the wild-type DRG neurons, the application of
A2764 (100 mM, in low-K1 recording solution) depolarized
the membrane potential by 6.6 6 5.1 mV, from 257.3 6 8.5
to 250.7 6 12.5 mV (P , 0.05, paired t test; n 5 15) (for
representative recording, see Fig. 6A, middle panel). In
TRESK KO DRG neurons, the application of A2764 did not
change the restingmembrane potential (255.86 7.3 vs.255.0
6 7.6 mV, before and after A2764, respectively, n 5 13) (for
representative recording, see Fig. 6B, middle panel). The
effect of A2764 on the membrane potential was significantly
different between the wild-type and the KO animals (P, 0.05,
Fig. 4. A2793 is an inhibitor of mTRESK and mTASK-1.
(A) mTRESK was expressed in Xenopus oocytes. The
oocytes were challenged with A2793 (100 mM). The
current measured in 80 mM K+ before application of
A2793 was 2.6 6 0.6 mA. Inhibition by A2793 was
determined and presented as described in Fig. 2A. (B)
The effect of A2793 on the activated mTRESK current
was determined under the same experimental conditions
detailed in Fig. 2B. The current measured in 80 mM K+
before the application of ionomycin was 1.7 6 0.7 mA.
Ionomycin activated the current by 6.7 6 2.0 fold. (C) To
determine the selectivity of A2793, mouse K2P channels
were expressed in Xenopus oocytes. The effect of A2793
on the inward current in 80 mM extracellular K+ (or
40 mM in the case of TREK-1, TREK-2, and TRAAK) was
determined in five oocytes per channel type, as in Fig. 3.
As a comparison, the data points corresponding to the
inhibition of TRESK current from (A andB) are also plotted.
Data are plotted as the mean + S.D. (D) Concentration-
response relationship of A2793 and mTRESK current. The
inhibitory effect of different concentrations of A2793 (in a
range from 1 to 100 mM) on basal (white circles) and
activated (black diamonds) TRESK current are plotted.
Each data point represents the average of five oocytes. The
data points were fitted with a modified Hill equation (see
Materials and Methods). iono, ionomycin.
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t test) (Fig. 7A), indicating that the depolarization by A2764
was mediated by the inhibition of TRESK.
We also investigated the effect of A2764 application on the
excitability of DRG neurons. The rheobase of DRG neurons
before and after the application of A2764 (100 mM) was
determined by the injection of depolarizing current impulses
of gradually increasing amplitude. The minimum amplitude
of current injection necessary for the generation of action
potential was reduced after the application of A2764 in most
neurons (for representative recording, see Fig. 6A, left and right
panels). The reduction of the rheobase was statistically signifi-
cant (control rheobase: 500 6 223 pA, n 5 6; A2764 rheobase:
3506 160 pA, n5 6; P, 0.05, paired t test) (Fig. 7B, left panel).
In sharp contrast, the rheobase of TRESK-deficient DRG neu-
rons was not influenced by A2764 (for representative recording,
see Fig. 6B, left and right panels). The rheobase was 320 6
130pA (n5 5) before and 3606134pA (n5 5) after, respectively,
the application of the cloxyquin derivative (Fig. 7B, right panel).
Fig. 6. A2764 increases the excitability of DRG neurons by inhibiting TRESK. DRG neurons isolated from either wild-type or TRESKKOmice were used
for current-clamp experiments. The rheobase was determined by injecting depolarizing current impulses in 100 pA increments before and after the
application of A2764 (100mM). The effect of A2764 (100mM)was determinedwithout any current injection (I = 0mode). (A) Representative recordings are
shown from a wild-type DRG neuron. (Left and right panels) The first traces where current injection resulted in an action potential before and after the
application of A2764 are plotted. (Middle panel) The application of A2764 leads to depolarization of the resting membrane potential. Application of the
drug is marked by the horizontal line above the recording. (B) Representative recordings are shown from a TRESK KO DRG neuron. (Left and right
panels) The first traces where current injection resulted in an action potential before and after the application of A2764 are plotted. (Middle panel) The
application of A2764 has no effect on the resting membrane potential. Application of the drug is marked by the horizontal line above the recording.
Fig. 5. A2764 inhibits the background K+ current in DRG
neurons. DRG neurons isolated from either wild-type or
TRESK KO mice were used for whole-cell patch-clamp
experiments. Inward currents were measured in 3.6 or
30 mM extracellular K+ at the end of 200-millisecond
voltage steps to 2100 mV from a holding potential of
280 mV. Changes in extracellular K+ concentration and
the application of A2764 (100 mM) and RR (30 mM) are
marked above the graphs. To convert TRESK channels
into their active state, the bath solution contained 0.5 mM
ionomycin. (A) A representative recording is shown from a
wild-type, A2764-sensitive DRG neuron. (B) The effect of
A2764 and RR on the background K+ current was mea-
sured in 10 DRG neurons. The degrees of inhibition by
A2764 and RR were plotted against each other. Linear
regression was performed, and the regression line was
plotted in addition to the data points (the corresponding
equation andR value are also shown). (C) A representative
recording is shown from a TRESK KO DRG neuron. (D)
The effect of A2764 and RR on the background K+ current
wasmeasured in eight DRGneurons isolated fromTRESK
KOmice. The degrees of inhibition by A2764 and RR were
plotted against each other.
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These data consistently indicate that the enhanced excit-
ability induced byA2764 relied on the inhibition of the TRESK
channel, which is a major determinant of action potential
generation in DRG neurons.
Discussion
K2P channels are expressed in a wide variety of cell types,
where they play a major role in the determination of the
resting membrane potential and in the regulation of cellu-
lar excitability (for review, see Enyedi and Czirják, 2010;
Feliciangeli et al., 2015). In comparison with the other
K2P channel subunits, the expression pattern of TRESK is
more restricted. The channel is abundantly and specifically
expressed in the primary sensory neurons of the DRG and
trigeminal ganglion. In accordance with this localization,
TRESK has been implicated in the modulation of both
physiological and pathophysiological nociception (for recent
reviews, see Enyedi and Czirják, 2015; Mathie and Veale,
2015). Important functional data highlighting TRESK as a
regulator of cellular excitability in primary sensory neurons
were obtained by eliminating TRESK (by transient knock-
down or by using KO animal strains), transiently overexpress-
ing the channel, or by using pharmacological modulators
of channel activity (Dobler et al., 2007; Tulleuda et al., 2011;
Guo and Cao, 2014). An accumulating body of evidence also
indicates that TRESK current alterations may contribute
to the pathologic mechanism of neuropathic, migraine, and
cancer pain (Lafrenière et al., 2010; Tulleuda et al., 2011;
Yang et al., 2018).
The examination of the role of TRESK in primary sensory
neurons is impeded by the lack of specific modulators. Several
pharmacological agents, including inorganic modulators as zinc
or mercuric ion (Czirják and Enyedi, 2006); the natural com-
pounds hydroxy-a-sanshool from Szechuan peppers (Bautista
et al., 2008); and aristolochic acid from Aristolochiaceae plants
(Veale and Mathie, 2016), approved medicines such as lamotri-
gine or verapamil (Kang et al., 2008; Park et al., 2018); and also
the insecticide pyrethroids (Castellanos et al., 2018) were
demonstrated to inhibit the TRESK current.
Although these agents are known to have other pharmaco-
logical targets in addition to TRESK, and in most cases they
were also shown to influence the activity of other K2P channels,
they provided the first options to experimentally manipulate
the TRESK current of sensory neurons. As another tool to
achieve this goal, cloxyquin, an antiamoebic drug, was identi-
fied as a TRESK activator in a high-throughput screening
(Wright et al., 2013). We have recently shown that cloxyquin is
selective for TRESK in the K2P family and can activate the
background K1 current in mouse DRG neurons (Lengyel et al.,
2017). Nevertheless, a high concentration of cloxyquin (in the
50–100 mM range) was required for TRESK activation. There-
fore, we have synthesized 28 chemically modified analogs of
cloxyquin to see whether we can find more potent activators of
TRESK. After a pilot screening on an mTRESK channel
expressed in Xenopus oocytes, it became apparent that the
potency of these derivatives for TRESK activation was not
increased by the chemical modification; however, their phar-
macological profile has been changed substantially. Some of the
analogs turned out to be inhibitors of TRESK, in sharp contrast
to the activator parent compound cloxyquin. We have chosen
the most potent analogs (one activator and two inhibitors) for
further analysis.
The A2797 compound activated mTRESK current about
4-fold at a 100mMconcentration. This degree of activationwas
similar to the previously reported effect of cloxyquin (Lengyel
et al., 2017). However, as opposed to the relative selectivity of
cloxyquin for TRESK in the K2P family, A2797 also activated
TREK-2, TASK-2, and TRAAK channels. This indicates that
the modification of the aromatic ring of cloxyquin may sub-
stantially influence the effect of the compound on various
members of the background potassium channel family.
Modification of the hydroxyl sidechain in the chlorinated
hydroxyquinoline parent molecule resulted in inhibitory deriv-
atives. We have recently reported that cloxyquin showed state
dependence in its effect; it was only able to activate TRESK
in the resting state, but not when the channel was acti-
vated by the Ca21/calcineurin pathway (Lengyel et al., 2017).
Fig. 7. Summary of the effect of A2764 on wild-type and TRESK KO DRG
neurons. (A) The resting membrane potential of 15 wild-type (left panel)
and 13 TRESK KO (right panel) DRG neurons was measured before
(Control) and after (100 mM)A2764 application. Data points corresponding
to one neuron are connected with a straight line. (B) The rheobase of six
wild-type (left panel) and five TRESK KO (right panel) DRG neurons was
measured before (Control) and after (100 mM) A2764 application. Data
points corresponding to one neuron are connected with a straight line.
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Intrigued by the possibility that our inhibitors also show state-
dependent effects, we determined the degree of inhibition by
A2793 for both the resting mTRESK and the channels
preactivated by application of the calcium ionophore ionomy-
cin. Interestingly, the state dependence of the effect of A2793
proved to be the mirror image of that of cloxyquin. The
inhibition by the compound was definitely more pronounced
when TRESK current was stimulated with ionomycin before
the application of A2793 than under the resting conditions of
the channel.
The effect of A2793 was also tested on the other K2P
channels in addition to TRESK. It proved to be an efficient
inhibitor of TASK-1, which was also reported to be expressed
in some primary sensory neurons (Cooper et al., 2004). The
effect on TASK-1 may limit the potential usage of A2793 to
selectively inhibit TRESK in the native cells coexpressing
these two specific K2P channels. However, A2793 may be
considered as a tool to discriminate between the resting and
activated channels in heterologous expression systems, and to
block TRESK activated by calcineurin in the native cells,
which do not express TASK-1.
The other cloxyquin derivative A2764 was also found to
exert a state-dependent effect. Similar to A2793, inhibition by
this compound was larger in the case of the activated TRESK
than at the resting channel. The concentration-response
relationship between A2764 and the mTRESK current was
also shifted to the left by the calcineurin-dependent dephos-
phorylation of the channel induced by the application of the
Ca21 ionophore ionomycin.
We have also determined the effect of A2764 on the other
K2P channels expressed in Xenopus oocytes. The substantial
inhibition of TASK-1 (by A2793) was missing from the profile
of A2764; thus, A2764 showed much better overall selectivity
for TRESK among the K2P channels than the other inhibitor.
The degree of inhibition of the most affected other K2P
channels (TREK-1 and TALK-1) was moderate (21.0% 6
9.7% and 22.4% 6 10.3%, respectively), compared with the
robust inhibition of dephosphorylated TRESK (77.8%6 3.5%),
suggesting that A2764 could be used as a selective inhibitor of
TRESK in isolated cells in vitro.
To test the hypothesis that A2764 can be applied to inhibit
TRESK and thus determine the contribution of the channel to
the ensemble background K1 current in native cells, we have
performed whole-cell patch-clamp experiments in DRG neu-
rons from both wild-type and TRESK KO mice. Based on
previous single channel and immunocytochemical results, in
the DRG neurons primarily the expression of two major K2P
channels, TRESK and TREK-2 was expected (Acosta et al.,
2014; Kang and Kim, 2006). To estimate the contribution of
these channels to the background K1 current by a further
independent method, we determined the degree of inhibi-
tion by A2764 and RR. We have previously described that
RR inhibits background K1 currents in DRG neurons
(Braun et al., 2015). The molecular correlates of the RR-
sensitive K1 current may be TREK-2, TASK-3, or TRAAK
homodimers, or heterodimers of the TREK subfamily (Braun
et al., 2015; Blin et al., 2016; Lengyel et al., 2016). We found
that in neurons derived from wild-type animals, A2764
strongly inhibited the background K1 current in a subset of
DRG neurons. However, this subset of A2764-sensitive neu-
rons was completely missing from the DRG neurons prepared
from TRESK KO animals. Based on these results from the
wild-type and TRESK KO DRG neurons, we propose that
A2764 is a useful selective inhibitor of TRESK.
To determine the contribution of TRESK and the RR-
sensitive channels to the background K1 current, the sensi-
tivity of the current to the two inhibitors was determined
in the same DRG neurons. We found an inverse correla-
tion between the amplitude of the A2764-sensitive and RR-
sensitive currents, indicating that the cells where TRESK
is the major determinant of the background K1 current
express relatively less RR-sensitive K2P channels and vice
versa. In the DRG neurons analyzed, around 80% of the
background K1 current was sensitive to the combination of
A2764 and RR. We have thus shown for the first time using
whole-cell patch clamp that TRESK and various RR-sensitive
K2P subunits are the major determinants of the background
K1 current of isolated mouse DRG neurons. The application
of A2764 offers a viable alternative to the previous methods
for the investigation of TRESK and its regulation in the
different functionally important subpopulations of primary
sensory neurons.
In good accordance with the efficient inhibition of TRESK
current by A2764, the application of this inhibitor also
depolarized DRG neurons and appreciably increased their
excitability in vitro, as indicated by the decreased rheobase in
current-clamp experiments. Since these effects and also the
inhibition of the background K1 current was completely
absent in the neurons isolated from the KO animals, we
concluded that the current component blocked by A2764
corresponds to TRESK. We propose that cloxyquin and A2764
can be used to modulate the activity of TRESK channels in
native cells, and that the TRESKKOmouse line can serve as a
reliable negative control in these experiments. We hope that
with this combined genetic and pharmacological approach the
functional relevance of the enigmatic TRESK channel can be
further elucidated.
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